HRES 803
119th Congress • 2025-2027 (Current)

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.


HRES 803
Oct 10, 2025
Referred to the House Committee on Energy and Commerce.